Business
Eli Lilly Plans $3.5 Billion Pennsylvania Plant For Obesity Drugs
By CNBC
Eli Lilly on Friday said it will spend more than $3.5 billion to build a manufacturing plant in Pennsylvania's Lehigh Valley that will help make its next-generation obesity drugs.
That includes a closely watched experimental drug called retatrutide, ...Read more
